Wall Street Journal
Bristol-Myers immunotherapy combo promising in melanoma-study
April 20 (Reuters) - A combination of two Bristol-Myers Squibb drugs that help the immune system fight melanoma led to significantly greater tumor shrinkage than treatment with one of the medicines, according to a midstage study presented on Monday.
Bristol-Myers: 2 cancer drugs beat 1 against melanoma
Bristol-Myers Drug Combination Shows Promise Against Melanoma
First Randomized Study Evaluating Opdivo (nivolumab)+Yervoy (ipilimumab ...
by via Health - Google News